Consistent with our finding, multiple independent researchers have suggested that Cav-1 usually exhibited decreased expression in breast cancer cells than normal cells (18) while Cav-1 loss usually predicated a poor clinical outcome of breast cancer patients (48–50). The gene discussed is CAV1; the disease is breast carcinoma.